The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Liver fibrosis: Pathophysiology and clinical implications
Open accessAbstract
Liver fibrosis is a clinically significant finding that has major impacts on patient morbidity and mortality. The mechanism of fibrosis involves many different cellular pathways, but the major cell type involved appears to be hepatic stellate cells. Many liver diseases, including Hepatitis B, C, and fatty liver disease cause ongoing hepatocellular damage leading to liver fibrosis. No matter the cause of liver disease, liver‐related mortality increases exponentially with increasing fibrosis. The progression to cirrhosis brings more dramatic mortality and higher incidence of hepatocellular carcinoma. Fibrosis can also affect outcomes following liver transplantation in adult and pediatric patients and require retransplantation. Drugs exist to treat Hepatitis B and C that reverse fibrosis in patients with those viral diseases, but there are currently no therapies to directly treat liver fibrosis. Several mouse models of chronic liver diseases have been successfully reversed using novel drug targets with current therapies focusing mostly on prevention of myofibroblast activation. Further research in these areas could lead to development of drugs to treat fibrosis, which will have invaluable impact on patient survival. This article is categorized under: Metabolic Diseases > Molecular and Cellular Physiology
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016) · Hepatology · doi:10.1002/hep.28431 · Cited by 10,781
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Histological grading and staging of chronic hepatitis
Ishak, K., Baptista, A., Bianchi, L., Callea, F., De Groote, J., Gudat, F., Denk, H., Desmet, V., Korb, G., MacSween, R. N. M., et al. (1995) · Journal of Hepatology · doi:10.1016/0168-8278(95)80226-6 · Cited by 5,029
A Model to Predict Survival in Patients With End–Stage Liver Disease
Kamath, P. S., Wiesner, R. H., Malinchoc, M., Kremers, W., Therneau, T. M., Kosberg, C. L., D'Amico, G., Dickson, R. E., & Kim, R. W. (2001) · Hepatology · doi:10.1053/jhep.2001.22172 · Cited by 4,975
Bataller, R., & Brenner, D. A. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24282 · Cited by 4,958
Knodell, R. G., Ishak, K. G., Black, W. C., Chen, T. S., Craig, R., Kaplowitz, N., Kiernan, T. W., & Wollman, J. (1981) · Hepatology · doi:10.1002/hep.1840010511 · Cited by 3,522
Angulo, P., Kleiner, D. E., Dam-Larsen, S., Adams, L. A., Bjornsson, E. S., Charatcharoenwitthaya, P., Mills, P. R., Keach, J. C., Lafferty, H. D., Stahler, A., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.043 · Cited by 2,987
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.014 · Cited by 2,591
Ekstedt, M., Hagström, H., Nasr, P., Fredrikson, M., Stål, P., Kechagias, S., & Hultcrantz, R. (2015) · Hepatology · doi:10.1002/hep.27368 · Cited by 2,287
Nonalcoholic Fatty Liver Disease: A Systematic Review
Rinella, M. E. (2015) · JAMA · doi:10.1001/jama.2015.5370 · Cited by 2,267
Deaths: Leading Causes for 2017.
Heron, M. P. (2019) · PubMed · Cited by 2,108
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965
Asahara, T., Takahashi, T., Masuda, H., Kalka, C., Chen, D., Iwaguro, H., Inai, Y., Silver, M., & Isner, J. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.14.3964 · Cited by 1,856
Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788
Classification of chronic viral hepatitis: a need for reassessment
Scheuer, P. J. (1991) · Journal of Hepatology · doi:10.1016/0168-8278(91)90084-o · Cited by 1,576
Bataller, R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200524282c1 · Cited by 1,472
Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis
Promrat, K., Kleiner, D. E., Niemeier, H. M., Jackvony, E., Kearns, M., Wands, J. R., Fava, J. L., & Wing, R. R. (2010) · Hepatology · doi:10.1002/hep.23276 · Cited by 1,330
Iredale, J. P., Benyon, R. C., Pickering, J., McCullen, M., Northrop, M., Pawley, S., Hovell, C., & Arthur, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1018 · Cited by 1,075
Ramachandran, P., Pellicoro, A., Vernon, M. A., Boulter, L., Aucott, R. L., Ali, A., Hartland, S. N., Snowdon, V. K., Cappon, A., Gordon-Walker, T. T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119964109 · Cited by 1,001
Hepatic inflammation and fibrosis: Functional links and key pathways
Seki, E., & Schwabe, R. F. (2015) · Hepatology · doi:10.1002/hep.27332 · Cited by 972
Barry-Hamilton, V., Spangler, R., Marshall, D., McCauley, S., Rodriguez, H. M., Oyasu, M., Mikels, A., Vaysberg, M., Ghermazien, H., Wai, C., et al. (2010) · Nature Medicine · doi:10.1038/nm.2208 · Cited by 870
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
Tapper, E. B., & Parikh, N. D. (2018) · BMJ · doi:10.1136/bmj.k2817 · Cited by 856
Vilar-Gomez, E., Calzadilla-Bertot, L., Wai-Sun Wong, V., Castellanos, M., Aller-de la Fuente, R., Metwally, M., Eslam, M., Gonzalez-Fabian, L., Alvarez-Quiñones Sanz, M., Conde-Martin, A. F., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.034 · Cited by 806
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis
Kisseleva, T., Cong, M., Paik, Y., Scholten, D., Jiang, C., Benner, C., Iwaisako, K., Moore-Morris, T., Scott, B., Tsukamoto, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1201840109 · Cited by 805
Self-citationKarlmark, K. R., Weiskirchen, R., Zimmermann, H. W., Gassler, N., Ginhoux, F., Weber, C., Merad, M., Luedde, T., Trautwein, C., & Tacke, F. (2009) · Hepatology · doi:10.1002/hep.22950 · Cited by 782
Feldstein, A. E., Charatcharoenwitthaya, P., Treeprasertsuk, S., Benson, J. T., Enders, F. B., & Angulo, P. (2009) · Gut · doi:10.1136/gut.2008.171280 · Cited by 726
TGF-β in progression of liver disease
Dooley, S., & ten Dijke, P. (2012) · Cell and Tissue Research · doi:10.1007/s00441-011-1246-y · Cited by 718
Meng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
Self-citationBala, S., Petrasek, J., Mundkur, S., Catalano, D., Levin, I., Ward, J., Alao, H., Kodys, K., & Szabo, G. (2012) · Hepatology · doi:10.1002/hep.25873 · Cited by 631
Galectin-3 regulates myofibroblast activation and hepatic fibrosis
Henderson, N. C., Mackinnon, A. C., Farnworth, S. L., Poirier, F., Russo, F. P., Iredale, J. P., Haslett, C., Simpson, K. J., & Sethi, T. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511167103 · Cited by 625
Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study
Merle, U., Schaefer, M., Ferenci, P., & Stremmel, W. (2007) · Gut · doi:10.1136/gut.2005.087262 · Cited by 625
Baeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Radaeva, S., Sun, R., Pan, H.-N., Hong, F., & Gao, B. (2004) · Hepatology · doi:10.1002/hep.20184 · Cited by 597
Evolving therapies for liver fibrosis
Schuppan, D., & Kim, Y. O. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66028 · Cited by 595
Ioannou, G. N., Green, P. K., & Berry, K. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.030 · Cited by 573
Competing risks and prognostic stages of cirrhosis: a 25‐year inception cohort study of 494 patients
D'Amico, G., Pasta, L., Morabito, A., D'Amico, M., Caltagirone, M., Malizia, G., Tinè, F., Giannuoli, G., Traina, M., Vizzini, G., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12721 · Cited by 547
Berenguer, M., Prieto, M., Rayón, J. M., Mora, J., Pastor, M., Ortiz, V., Carrasco, D., Juan, F. S., Burgueño, M.-D.-J., Mir, J., et al. (2000) · Hepatology · doi:10.1053/jhep.2000.17924 · Cited by 544
Origin of myofibroblasts in the fibrotic liver in mice
Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535
Self-citationER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Nakagawa, H., Umemura, A., Taniguchi, K., Font-Burgada, J., Dhar, D., Ogata, H., Zhong, Z., Valasek, M. A., Seki, E., Hidalgo, J., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.07.001 · Cited by 525
Deactivation of Hepatic Stellate Cells During Liver Fibrosis Resolution in Mice
Troeger, J. S., Mederacke, I., Gwak, G., Dapito, D. H., Mu, X., Hsu, C. C., Pradere, J., Friedman, R. A., & Schwabe, R. F. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.06.036 · Cited by 515
Kisseleva, T., & Brenner, D. A. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-190 · Cited by 503
Self-citationLiver sinusoidal endothelial cells in hepatic fibrosis
DeLeve, L. D. (2015) · Hepatology · doi:10.1002/hep.27376 · Cited by 482 · cited 1×
“Moreover, following disruption of the endothelium, LSECs will secrete profibrogenic cytokines like TGF-β1, PDGF, interleukins, tumor necrosis factor α (TNFα), and VEGF, which will recruit inflammatory cells to the site of injury and activate HSCs (DeLeve, 2015).”
BackgroundBone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis
Kisseleva, T., Uchinami, H., Feirt, N., Quintana-Bustamante, O., Segovia, J. C., Schwabe, R. F., & Brenner, D. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.04.014 · Cited by 469
Self-citationRinella, M. E., & Green, R. M. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.09.020 · Cited by 460
Bhala, N., Angulo, P., van der Poorten, D., Lee, E., Hui, J. M., Saracco, G., Adams, L. A., Charatcharoenwitthaya, P., Topping, J. H., Bugianesi, E., et al. (2011) · Hepatology · doi:10.1002/hep.24491 · Cited by 450
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Kong, X., Feng, D., Wang, H., Hong, F., Bertola, A., Wang, F.-S., & Gao, B. (2012) · Hepatology · doi:10.1002/hep.25744 · Cited by 448
Ki, S. H., Park, O., Zheng, M., Morales-Ibanez, O., Kolls, J. K., Bataller, R., & Gao, B. (2010) · Hepatology · doi:10.1002/hep.23837 · Cited by 434
CCR1 and CCR5 promote hepatic fibrosis in mice
Seki, E., De Minicis, S., Gwak, G.-Y., Kluwe, J., Inokuchi, S., Bursill, C. A., Llovet, J. M., Brenner, D. A., & Schwabe, R. F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37444 · Cited by 431
Mechanisms of liver fibrosis and its role in liver cancer
Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 429
Self-citationIncidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012
White, D. L., Thrift, A. P., Kanwal, F., Davila, J., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.11.020 · Cited by 418
CCR2 promotes hepatic fibrosis in mice #
Seki, E., de Minicis, S., Inokuchi, S., Taura, K., Miyai, K., van Rooijen, N., Schwabe, R. F., & Brenner, D. A. (2009) · Hepatology · doi:10.1002/hep.22952 · Cited by 416
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Wang, X., Zheng, Z., Caviglia, J. M., Corey, K. E., Herfel, T. M., Cai, B., Masia, R., Chung, R. T., Lefkowitch, J. H., Schwabe, R. F., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.016 · Cited by 413
Clinical evidence for the regression of liver fibrosis
Ellis, E. L., & Mann, D. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.09.024 · Cited by 411
Xie, G., Wang, X., Wang, L., Wang, L., Atkinson, R. D., Kanel, G. C., Gaarde, W. A., & DeLeve, L. D. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.017 · Cited by 410
DeLeve, L. D., Wang, X., & Guo, Y. (2008) · Hepatology · doi:10.1002/hep.22351 · Cited by 408
The role of TGFβ1 in initiating hepatic stellate cell activation in vivo
Hellerbrand, C., Stefanovic, B., Giordano, F., Burchardt, E. R., & Brenner, D. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80010-5 · Cited by 393
Ip, E., Farrell, G., Hall, P., Robertson, G., & Leclercq, I. (2004) · Hepatology · doi:10.1002/hep.20170 · Cited by 383
Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases
Gao, B., Radaeva, S., & Park, O. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0309135 · Cited by 377
A New Xenobiotic-Induced Mouse Model of Sclerosing Cholangitis and Biliary Fibrosis
Fickert, P., Stöger, U., Fuchsbichler, A., Moustafa, T., Marschall, H.-U., Weiglein, A. H., Tsybrovskyy, O., Jaeschke, H., Zatloukal, K., Denk, H., et al. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.061133 · Cited by 376
The Physiology of Obese-Hyperglycemic Mice [ob/ob Mice]
Lindström, P. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.117 · Cited by 356
Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial
Zein, C. O., Yerian, L. M., Gogate, P., Lopez, R., Kirwan, J. P., Feldstein, A. E., & McCullough, A. J. (2011) · Hepatology · doi:10.1002/hep.24544 · Cited by 356
Grønbæk, L., Vilstrup, H., & Jepsen, P. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.10.020 · Cited by 355
Th, M., van Nieuwkerk, C. M., Dingemans, K. P., Smit, J. J., Schinkel, A. H., Notenboom, R. G. E., Weerman, M. A. V. D. B., VERKRUISEN, R. P., Groen, A. K., & Elferink, R. P. J. O. (1994) · PubMed · Cited by 349
Animal models of NASH: Getting both pathology and metabolic context right
Larter, C. Z., & Yeh, M. M. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05543.x · Cited by 337
Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336
Hepatocytes Do Not Undergo Epithelial-Mesenchymal Transition in Liver Fibrosis in Mice
Taura, K., Miura, K., Iwaisako, K., Österreicher, C. H., Kodama, Y., Penz-Österreicher, M., & Brenner, D. A. (2010) · Hepatology · doi:10.1002/hep.23368 · Cited by 336
Liedtke, C., Luedde, T., Sauerbruch, T., Scholten, D., Streetz, K., Tacke, F., Tolba, R., Trautwein, C., Trebicka, J., & Weiskirchen, R. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-19 · Cited by 335
Hepatic Stellate Cell Behavior during Resolution of Liver Injury
Iredale, J. P. (2001) · Seminars in Liver Disease · doi:10.1055/s-2001-17557 · Cited by 333
Fibrosis and alcohol-related liver disease
Lackner, C., & Tiniakos, D. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.12.003 · Cited by 322
The ultrastructure of fatty liver induced by prolonged ethanol ingestion.
Iseri, O. A., Lieber, C. S., & Gottlieb, L. S. (1966) · PubMed Central · Cited by 311
Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation
DeLeve, L. D., Wang, X., Hu, L., McCuskey, M. K., & McCuskey, R. S. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00017.2004 · Cited by 296
Lackner, C., Spindelboeck, W., Haybaeck, J., Douschan, P., Rainer, F., Terracciano, L., Haas, J., Berghold, A., Bataller, R., & Stauber, R. E. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.011 · Cited by 293
Marra, F., DeFranco, R., Grappone, C., Milani, S., Pastacaldi, S., Pinzani, M., Romanelli, R. G., Laffi, G., & Geñtilini, P. (1998) · Europe PMC (PubMed Central) · Cited by 289
Portal fibroblasts: Underappreciated mediators of biliary fibrosis†
Dranoff, J. A., & Wells, R. G. (2010) · Hepatology · doi:10.1002/hep.23405 · Cited by 273
Vascular Endothelial Growth Factor Promotes Fibrosis Resolution and Repair in Mice
Yang, L., Kwon, J., Popov, Y., Gajdos, G. B., Ordog, T., Brekken, R. A., Mukhopadhyay, D., Schuppan, D., Bi, Y., Simonetto, D., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.061 · Cited by 256
Jiang, J. X., Chen, X., Serizawa, N., Szyndralewiez, C., Page, P., Schröder, K., Brandes, R. P., Devaraj, S., & Török, N. J. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.007 · Cited by 251
Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis
Zhu, C., Kim, K., Wang, X., Bartolome, A., Salomao, M., Dongiovanni, P., Meroni, M., Graham, M. J., Yates, K. P., Diehl, A. M., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aat0344 · Cited by 250
Reversibility of hepatic fibrosis in treated genetic hemochromatosis: A study of 36 cases
Falize, L., Guillygomarc'h, A., Perrin, M., Lainé, F., Guyader, D., Brissot, P., Turlin, B., & Deugnier, Y. (2006) · Hepatology · doi:10.1002/hep.21260 · Cited by 249
Jeong, W., Park, O., & Gao, B. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.09.034 · Cited by 247
Targeting Oxidative Stress for the Treatment of Liver Fibrosis
Luangmonkong, T., Suriguga, S., Mutsaers, H. A. M., Groothuis, G. M. M., Olinga, P., & Boersema, M. (2018) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/112_2018_10 · Cited by 245
Liver fibrosis induced by hepatic overexpression of PDGF-B in transgenic mice
Czochra, P., Klopcic, B., Meyer, E., Herkel, J., Garcia-Lazaro, J. F., Thieringer, F., Schirmacher, P., Biesterfeld, S., Galle, P. R., Lohse, A. W., et al. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.04.010 · Cited by 244
Kabbany, M. N., Selvakumar, P. K. C., Watt, K., Lopez, R., Akras, Z., Zein, N., Carey, W., & Alkhouri, N. (2017) · American Journal of Gastroenterology · doi:10.1038/ajg.2017.5 · Cited by 242
Tsukamoto, H., French, S. W., Benson, N., Delgado, G., Rao, A. G., Larkin, E. C., & Largman, C. (1985) · Hepatology · doi:10.1002/hep.1840050212 · Cited by 238
Lee, Y.-S., Kim, S. Y., Ko, E., Lee, J.-H., Yi, H.-S., Yoo, Y. J., Je, J., Suh, S. J., Jung, Y. K., Kim, J. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03389-2 · Cited by 233
Rouach, H., Fataccioli, V, Gentil, M., French, S. W., Morimoto, M., & Nordmann, R. (1997) · Hepatology · doi:10.1002/hep.510250216 · Cited by 233
Yalamanchili, K., Saadeh, S., Klintmalm, G. B., Jennings, L. W., & Davis, G. L. (2010) · Liver Transplantation · doi:10.1002/lt.22004 · Cited by 227
Scholten, D., Österreicher, C. H., Scholten, A., Iwaisako, K., Gu, G., Brenner, D. A., & Kisseleva, T. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.005 · Cited by 227
Self-citationTraber, P. G., Chou, H., Zomer, E., Hong, F., Klyosov, A., Fiel, M.-I., & Friedman, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075361 · Cited by 214
Brown, R. S., Kumar, S. K., Russo, M. W., Kinkhabwala, M., Rudow, D. L., Harren, P., Lobritto, S., & Emond, J. C. (2002) · Liver Transplantation · doi:10.1053/jlts.2002.31340 · Cited by 210
Lan, T., Kisseleva, T., & Brenner, D. A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129743 · Cited by 209
Self-citationEverhart, J. E., Wright, E. C., Goodman, Z. D., Dienstag, J. L., Hoefs, J. C., Kleiner, D. E., Ghany, M. G., Mills, S. A., Nash, R. S., Govindarajan, S., et al. (2010) · Hepatology · doi:10.1002/hep.23315 · Cited by 208
Issa, R., Zhou, X., Trim, N., Millward‐Sadler, H., Krane, S., Benyon, C., & Iredale, J. (2003) · The FASEB Journal · doi:10.1096/fj.02-0494fje · Cited by 208
Metabolism and Toxicity of Thioacetamide and Thioacetamide S-Oxide in Rat Hepatocytes
Hajovsky, H., Hu, G., Koen, Y., Sarma, D., Cui, W., Moore, D. S., Staudinger, J. L., & Hanzlik, R. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx3002719 · Cited by 203
Experimental models of non-alcoholic fatty liver disease in rats
Kucera, O. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i26.8364 · Cited by 195
Kodama, Y., Kisseleva, T., Iwaisako, K., Miura, K., Taura, K., De Minicis, S., Österreicher, C. H., Schnabl, B., Seki, E., & Brenner, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.06.045 · Cited by 195
Self-citationParsons, C. J., Bradford, B. U., Pan, C. Q., Cheung, E., Schauer, M., Knorr, A., Krebs, B., Kraft, S., Zahn, S., Brocks, B., et al. (2004) · Hepatology · doi:10.1002/hep.20425 · Cited by 193
Loss of MMP 13 attenuates murine hepatic injury and fibrosis during cholestasis
Uchinami, H., Seki, E., Brenner, D. A., & D'Armiento, J. (2006) · Hepatology · doi:10.1002/hep.21268 · Cited by 193
Time course of histological progression in primary biliary cirrhosis
Locke, G. R., Therneau, T. M., Ludwig, J., Dickson, E. R., & Lindor, K. D. (1996) · Hepatology · doi:10.1002/hep.510230108 · Cited by 184
Vadasz, Z., Kessler, O., Akiri, G., Gengrinovitch, S., Kagan, H. M., Baruch, Y., Izhak, O. B., & Neufeld, G. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.02.052 · Cited by 182
Prevalence of Alcoholic Fatty Liver Disease Among Adults in the United States, 2001-2016
Wong, T., Dang, K., Ladhani, S., Singal, A. K., & Wong, R. J. (2019) · JAMA · doi:10.1001/jama.2019.2276 · Cited by 181
Harrison, S. A., Marri, S. R., Chalasani, N., Kohli, R., Aronstein, W., Thompson, G. A., Irish, W., Miles, M. V., Xanthakos, S. A., Lawitz, E., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13816 · Cited by 176
Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under Development
(2015) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2014.00035 · Cited by 171
Salguero Palacios, R., Roderfeld, M., Hemmann, S., Rath, T., Atanasova, S., Tschuschner, A., Gressner, O. A., Weiskirchen, R., Graf, J., & Roeb, E. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.91 · Cited by 170
Anti-fibrogenic strategies and the regression of fibrosis
Kisseleva, T., & Brenner, D. A. (2011) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2011.02.011 · Cited by 169
Self-citationBettaieb, A., Jiang, J. X., Sasaki, Y., Chao, T.-I., Kiss, Z., Chen, X., Tian, J., Katsuyama, M., Yabe-Nishimura, C., Xi, Y., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.009 · Cited by 167
Reproducible production of thioacetamide-induced macronodular cirrhosis in the rat with no mortality
Li, X., Benjamin, I. S., & Alexander, B. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00011-9 · Cited by 167
Hyaluronan synthase 2–mediated hyaluronan production mediates Notch1 activation and liver fibrosis
Yang, Y. M., Noureddin, M., Liu, C., Ohashi, K., Kim, S. Y., Ramnath, D., Powell, E. E., Sweet, M. J., Roh, Y. S., Hsin, I.-F., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat9284 · Cited by 166
de Gouville, A., Boullay, V., Krysa, G., Pilot, J., Brusq, J., Loriolle, F., Gauthier, J., Papworth, S. A., Laroze, A., Gellibert, F., et al. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706172 · Cited by 166
Stål, P. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11077 · Cited by 159
Feng, D., Kong, X., Weng, H., Park, O., Wang, H., Dooley, S., Gershwin, M. E., & Gao, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.03.044 · Cited by 159
Type 3 cytokines IL-17A and IL-22 drive TGF-β–dependent liver fibrosis
Fabre, T., Molina, M. F., Soucy, G., Goulet, J.-P., Willems, B., Villeneuve, J.-P., Bilodeau, M., & Shoukry, N. H. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar7754 · Cited by 155
Desmoulière, A., Darby, I. A., Costa, A., Raccurt, M., Tuchweber, B., Sommer, P., & Gabbiani, G. (1997) · PubMed · Cited by 146
Beste, L. A., Green, P. K., Berry, K., Kogut, M. J., Allison, S. K., & Ioannou, G. N. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.02.027 · Cited by 142
Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
Rodrı́guez, H. M., Vaysberg, M., Mikels, A. J., McCauley, S., Velayo, A. C., García, C., & Smith, V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.094136 · Cited by 139
Popov, Y., Sverdlov, D. Y., Bhaskar, K. R., Sharma, A. K., Millonig, G., Patsenker, E., Krahenbuhl, S., Krahenbuhl, L., & Schuppan, D. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00394.2009 · Cited by 136
Carbon tetrachloride toxicity as a model for studying free-radical mediated liver injury
Slater, T. F., Cheeseman, K. H., & Ingold, K. U. (1985) · Philosophical transactions of the Royal Society of London. Series B, Biological sciences · doi:10.1098/rstb.1985.0169 · Cited by 130
Mathews, S., Xu, M., Wang, H., Bertola, A., & Gao, B. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00041.2014 · Cited by 129
Cross-talk between Notch and Hedgehog regulates hepatic stellate cell fate in mice
Xie, G., Karaca, G., Swiderska‐Syn, M., Michelotti, G. A., Krüger, L., Chen, Y., Premont, R. T., Choi, S. S., & Diehl, A. M. (2013) · Hepatology · doi:10.1002/hep.26511 · Cited by 127
A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the rat
Jenkins, S. A., Grandison, A. S., Baxter, J. N., et al. (1985) · Journal of Hepatology · doi:10.1016/s0168-8278(85)80747-9 · Cited by 126
Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity
Kang, J. S., Wanibuchi, H., Morimura, K., Wongpoomchai, R., Chusiri, Y., Gonzalez, F. J., & Fukushima, S. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.11.010 · Cited by 123
Kelly, D. A., Verkade, H. J., Rajanayagam, J., McKiernan, P. J., Mazariegos, G. V., & Hübscher, S. G. (2016) · Liver Transplantation · doi:10.1002/lt.24616 · Cited by 120
Liver Fibrosis in Alcoholic Liver Disease
Bataller, R., & Gao, B. (2015) · Seminars in liver disease (Print) · doi:10.1055/s-0035-1550054 · Cited by 114
Langer, D., Das, A., Semela, D., Kang, N., Hendrickson, H. I., Bronk, S. F., Katušić, Z. S., Gores, G. J., & Shah, V. H. (2008) · Hepatology · doi:10.1002/hep.22285 · Cited by 112
Clinical Advancements in the Targeted Therapies against Liver Fibrosis
Bansal, R., Nagórniewicz, B., & Prakash, J. (2016) · Mediators of Inflammation · doi:10.1155/2016/7629724 · Cited by 110
Migration of Fibrocytes in Fibrogenic Liver Injury
Scholten, D., Reichart, D. R., Paik, Y. H., Lindert, J., Bhattacharya, J., Glass, C. K., Brenner, D. A., & Kisseleva, T. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.03.049 · Cited by 108
Self-citationMouse intragastric infusion (iG) model
Ueno, A. M., Lazaro, R. G., Wang, P., Higashiyama, R., Machida, K., & Tsukamoto, H. (2012) · Nature Protocols · doi:10.1038/nprot.2012.014 · Cited by 106
Piñero, F., Mendizábal, M., Ridruejo, E., Wolff, F. H., Ameigeiras, B., Anders, M., Schinoni, M. I., Reggiardo, V., Palazzo, A., Videla, M. G., et al. (2019) · Liver International · doi:10.1111/liv.14041 · Cited by 92
Pathogenesis of biliary fibrosis
Pinzani, M., & Luong, T. V. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.07.026 · Cited by 90
Sullivan, B. P., Weinreb, P. H., Violette, S. M., & Luyendyk, J. P. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.100425 · Cited by 84
Chiang, D. J., Roychowdhury, S., Bush, K., McMullen, M. R., Pisano, S. G., Niese, K. A., Olman, M. A., Pritchard, M. T., & Nagy, L. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069114 · Cited by 83
Fibrosis in Chronic Liver Disease: An Update on Diagnostic and Treatment Modalities
Manka, P. P., Zeller, A. C., & Syn, W. (2019) · Drugs · doi:10.1007/s40265-019-01126-9 · Cited by 80
Kitamura, K., Nakamoto, Y., Akiyama, M., Fujii, C., Kondo, T., KOBAYASHI, K. P., Kaneko, S., & Mukaida, N. (2002) · Laboratory Investigation · doi:10.1038/labinvest.3780452 · Cited by 68
Iimuro, Y., Ikejima, K., Rose, M., Bradford, B. U., & Thurman, R. G. (1996) · Hepatology · doi:10.1002/hep.510240217 · Cited by 66
Nilsson, E., Anderson, H., Sargenti, K., Lindgren, S. C., & Prytz, H. (2019) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15255 · Cited by 65
Lefebvre, E. A., Gottwald, M. D., Lasseter, K. C., Chang, W., Willett, M. S., Smith, P. F., Somasunderam, A., & Utay, N. S. (2016) · Clinical and Translational Science · doi:10.1111/cts.12397 · Cited by 58
Treatment of thioacetamide-induced liver cirrhosis by the Ras antagonist, farnesylthiosalicylic acid
Reif, S. S., Aeed, H., Shilo, Y., Reich, R., Kloog, Y., Kweon, Y. O., & Bruck, R. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.04.010 · Cited by 54
Vascular biology and pathobiology of the liver: Report of a single-topic symposium
Iwakiri, Y., Grisham, M. B., & Shah, V. H. (2008) · Hepatology · doi:10.1002/hep.22203 · Cited by 53
Evaluation of Liver Fatty Acid Oxidation in the Leptin-Deficient Obese Mouse
Brix, A. E., Elgavish, A., Nagy, T. R., Gower, B. A., Rhead, W. J., & Wood, P. A. (2002) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2002.3298 · Cited by 37
Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse
Riordan, J. D., & Nadeau, J. H. (2014) · Mammalian Genome · doi:10.1007/s00335-014-9521-3 · Cited by 36
Angiogenesis: a phenomenon which aggravates chronic liver disease progression
Kukla, M. (2012) · Hepatology International · doi:10.1007/s12072-012-9391-2 · Cited by 36
Borkham‐Kamphorst, E., Meurer, S. K., de Leur, E. V., Haas, U., Tihaa, L., & Weiskirchen, R. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.03.012 · Cited by 34
Shoreibah, M., Raff, E., Bloomer, J. R., Kakati, D., Rasheed, K., Kuo, Y., & Singal, A. K. (2016) · PubMed · doi:10.5604/16652681.1193707 · Cited by 31
Long-term challenges and perspectives of pre-adolescent liver disease
Hadžić, N., Baumann, U., McKiernan, P. J., McLin, V. A., & Nobili, V. (2017) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(16)30160-1 · Cited by 26
Attenuation of hepatic fibrosis by an imidazolium salt in thioacetamide‐induced mouse model
Ding, Z., & Zhuo, L. (2012) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2012.07265.x · Cited by 25
Looking Into the Crystal Ball: Predicting the Future Challenges of Fibrotic NASH Treatment
Alkhouri, N., Lawitz, E., & Noureddin, M. (2019) · Hepatology Communications · doi:10.1002/hep4.1342 · Cited by 19
Varma, S., Stéphenne, X., Komuta, M., Bouzin, C., Ambroise, J., Smets, F. N., Reding, R., & Sokal, E. M. (2016) · Pediatric Transplantation · doi:10.1111/petr.12834 · Cited by 16
Vitamin E, but not pioglitazone, improved nonalcoholic steatohepatitis in nondiabetic patients
Mukherjee, S. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-153-6-201009210-02012 · Cited by 9
Temporal trends of cirrhosis associated conditions
Sempokuya, T., Zhang, G., & Nakagawa, K. (2019) · World Journal of Hepatology · doi:10.4254/wjh.v11.i1.74 · Cited by 6
The Costs of Hepatitis C by Liver Disease Stage: Estimates from the Veterans Health Administration
Gidwani, R. A., Owens, D. K., Lo, J., Goldhaber‐Fiebert, J. D., Asch, S. M., & Barnett, P. G. (2019) · Applied Health Economics and Health Policy · doi:10.1007/s40258-019-00468-5 · Cited by 5
Cited by
PPAR-γ signaling in nonalcoholic fatty liver disease: Pathogenesis and therapeutic targets
Chen, H., Tan, H., Wan, J., Zeng, Y., Wang, J., Wang, H., & Lu, X. (2023) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2023.108391 · Cited by 311
Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
Zhao, Y.-Q., Deng, X.-W., Xu, G.-Q., Lin, J., Lu, H.-Z., & Chen, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1183808 · Cited by 71
The Origin and Fate of Liver Myofibroblasts
Kim, H. Y., Sakane, S., Eguileor, A., Carvalho Gontijo Weber, R., Lee, W., Liu, X., Lam, K., Ishizuka, K., Rosenthal, S. B., Diggle, K., et al. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.09.008 · Cited by 63
Self-citationLhx2 specifically expressed in HSCs promotes liver regeneration and inhibits liver fibrosis
Tao, J., Wu, Z., Liang, Y., Wang, J., Tang, M., Huang, S., Jiang, F., Zhou, G., Guo, L., Yuan, S., et al. (2025) · Hepatology · doi:10.1097/hep.0000000000001201 · Cited by 19
Beyond M1/M2: The role of reactive oxygen species in liver fibrosis and immune modulation
Lu, H., Huang, J., Wang, Y.-C., Casals, E., Casals, G., & Zeng, M. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103933 · Cited by 19
Metadata
- Authors
- Berumen, J., Baglieri, J., Kisseleva, T., & Mekeel, K.
- Venue
- WIREs Mechanisms of Disease
- Publisher
- Wiley
- Published
- 2020-07-26
- Volume
- 13
- Issue
- 1
- Pages
- e1499-e1499
- ISSN
- 2692-9368 (ISSN-L)
- OpenAlex
- W3045287874
- Cited by
- 259
- References
- 150
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.